The "Elevate" by MAPS Podcast

In this second of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt thei...

The podcast objectives are to :  explain what publication plain-language summaries are and their value  share Pharma experience of developing PLS, including how to overcome any Pharma specific challenges   Moderator: Karen King PhD CMPP, Head of Medical Strategy, Growth & Development CMC Affinity, a McCann Health company Interviewee: Dheepa Chari, Head, Global Scientific Publications, Pfizer O...

MAPS speaks with Kent Summers, HEOR Lead at AlphaGroup and Steve Camper, VP of Medical Affairs at Blue Earth Diagnostics, about building Health Economics and Outcomes Research capabilities within Medical Affairs.

Objectives:  At the end of this series of podcasts, the participant should be able to: ·         Discuss the functions and activities of key internal partners ·         Identify potential areas for compliant collaboration by MSLs with key internal partners

This episode of the MAPS podcast series, Elevate, explores the differing approaches applied in the pharmaceutical and device industries to understand the impact and approach to acquired and internally generated data, analytics, and insights play in delivering value.  

The Series Podcast Objectives are:   Understand how the medical affairs strategic planning process can drive decision making throughout the year   Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed   Obtain a working knowledge of how cross-functional teams within medical affairs can reference strateg...

Even before the COVID-19 pandemic, the structure and content of interactions between MSLs and KOLs/HCPs was shifting, with MSLs increasingly seen as trusted partners in scientific exchange and KOLs/HCPs increasingly open to technology-based communications. Of course, the pandemic has accelerated this change, shifting the mechanics of communication and collaboration and throwing into focus the defi...

The Series Podcast Objectives are:   Understand how the medical affairs strategic planning process can drive decision making throughout the year   Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed   Obtain a working knowledge of how cross-functional teams within medical affairs can reference strateg...

Objectives:  At the end of this series of podcasts, the participant should be able to: ·         Discuss the functions and activities of key internal partners ·         Identify potential areas for compliant collaboration by MSLs with key internal partners

In this third podcast episode in collaboration with Open Health, MAPS speaks with Jessica Ingram, Managing Director of Learning and Development at Open Health, and two of her team: Briony Frost, Learning Design and Development Specialist, and Jessamy Lowe, Senior Account Handler. Joining Jess, Jessie, and Briony is Seema Haider. Seema is the former Health Economics and Outcomes Research Cluster Le...

 In this second episode of the MAPS podcast series Elevate with medical communications and educational design experts from Open Health, we explore the development and delivery of internal training for Medical Affairs professionals: How do we ensure people do the training and can we also design for engagement and motivation? Does this look different in the digital environment?   Speakers include th...

In partnership with Medical Communications and Educational Design experts from Open Health, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training. How do we go about designing effective, outcome-focused internal training? Can effective internal training also be efficient? And is it expensive? What are the benefits f...

Medical Affairs thought leaders discuss the Pre-21st Century Act uses of Real World Evidence (RWE) with Post-Marketing Surveillance to understand the impact of the 21st Century Act on RWE and Natural History Studies.

The Series Podcast Objectives are:   Understand how the medical affairs strategic planning process can drive decision making throughout the year   Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed   Obtain a working knowledge of how cross-functional teams within medical affairs can reference strateg...

Kathryn Gann, Independent Consultant , serves as the moderator for this session on Global Communications. In this podcast, Robin Winter-Sperry, MD, President & CEO , Scientific Resilience, interviews Aimee Christian, Ph. D., Global Head of Communications, Specialty Care , Sanofi-Genzyme. At the end of this series of podcasts, the audience should be able to: ·         Discuss the functions and...

In this first of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt their...

External experts play a key role in the success or failure of the innovations delivered by the pharma/biotech industry. In today’s environment, restrictions continue to impede broad access to practicing physicians who in turn have less autonomy and it’s harder to gain access to them. At the same time, the complexity of the science behind future products increases the needs for diverse involvement...

The Series Podcast Objectives are:   Understand how the medical affairs strategic planning process can drive decision making throughout the year   Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed   Obtain a working knowledge of how cross-functional teams within medical affairs can reference strateg...

In this first of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Contributions Medical Affairs Makes to Asset Strategic Plans; and Time Horizon, Refreshing, and Resourcing of a Medical Affairs Plan.  Panelists are:  Ed Gudaitis, MBA, President & CEO Acerus Pharma  Keith Johns, MBA, VP, Global Marketing and Alliance Man...

In this second of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Global/Regional/Local Planning; Approach to MA Strategic Planning - Rare Disease & Oncology; and, Compliance Considerations. Panelists are:  Tina Beaman, VP and Chief Compliance Officer, Karyopharm Therapeutics  Ed Gudaitis, President & CEO Acerus Ph...

Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Real World Evidence and its impact. The podcast objectives are: To define Real World Evidence, and to demonstrate RWE and its impact to Biotech/Pharma. Mr. Belson will address a variety of topics including: The significance of Real World Evidence for th...

In this second podcast on the EUMDR, panelists John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson & Johnson Medical Devices Companies welcomes Philip Desjardins, JD, Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, DePuy Synthes | Johnson & Johnson Medical Device...

Host John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson & Johnson Medical Devices Companies welcomes Philip Desjardins, JD, Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, DePuy Synthes | Johnson & Johnson Medical Devices Companies, and Drilon Saliu, PharmD, MBA...

Hosts John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Depuy Synthes - Spine | Johnson & Johnson Medical Devices Companies and Marc Rubinstein, MD, Medical Director at Instrumentation Laboratory, welcome panelists Huub Kreuwel PhD, Vice President of Scientific and Medical Affairs at Octapharma, and Sean Lilienfeld MBBCh, MMEd(Neuro)...

If you’re considering a career transition, asking: “What’s in it for me?” is just as important as “What’s in it for the company?” During this podcast, Dr. Rubinstein asks the panelists, Dr. Sean Lilienfeld and Huub Kreuwel, why they considered making the change from one area to another. The potential for expanding your skillsets is an important consideration but it is not the only one.